Gemseki Ventures L.P. Investment in PRISM BioLab

2021/09/09

Gemseki Ventures L.P. is pleased to announce our investment in PRISM BioLab. PRISM BioLab has a drug discovery platform with a library of small molecule compounds based on its unique peptide mimic technology.

Gemseki will stand with  PRISM BioLab to take on the challenges and continue to support drug developments that contribute to humanity and society.

 

Link: 株式会社 PRISM BioLab、13 億円のシリーズ C 資金調達を実施 (in Japanese)